CoChat

Novel therapeutic applications of cardiac glycosides

Prassas, Ioannis, Diamandis, Eleftherios P. · 2008 · Nature Reviews Drug Discovery

The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.

Abstract

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit Na+/K+-ATPase. Members of this family have been in clinical use for many years for the treatment of heart failure and atrial arrhythmia, and the mechanism of their positive inotropic effect is well characterized. Exciting recent findings have suggested additional signalling modes of action of Na+/K+-ATPase, implicating cardiac glycosides in the regulation of several important cellular processes and highlighting potential new therapeutic roles for these compounds in various diseases. Perhaps most notably, the increased susceptibility of cancer cells to these compounds supports their potential use as cancer therapies, and the first generation of glycoside-based anticancer drugs are currently in clinical trials.

Overview

Integrity signals

Registry

Crossref · 10.1038/nrd2682

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 135 references

Cited by

Items 301–400 of 669

Metadata

Authors
Prassas, I., & Diamandis, E. P.
Affiliations
  • University of Toronto (CA)
  • Mount Sinai Hospital (CA)
Corresponding author
Diamandis, Eleftherios P.
Venue
Nature Reviews Drug Discovery
Published
2008-10-24
Volume
7
Issue
11
Pages
926-935
ISSN
  • 1474-1776 (ISSN-L)
  • 1474-1784
OpenAlex
W2054405945
Cited by
673
References
134
Citations by year
2026: 16 · 2025: 38 · 2024: 40 · 2023: 50 · 2022: 37 · 2021: 51 · 2020: 47 · 2019: 43 · 2018: 41 · 2017: 44 · 2016: 40 · 2015: 41 · 2014: 43 · 2013: 40 · 2012: 41
FWCI
1.49
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Reviews Drug Discovery (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
  • Physical Sciences › Materials Science › Biomaterials › Phytochemistry and Bioactive Compounds
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
cardiac glycosides, Na+/K+-ATPase, signal transduction, heart failure, atrial arrhythmias, positive inotropic effect, anticancer agents, cancer therapy
MeSH terms
Sodium-Potassium-Exchanging ATPase, Animals, Antineoplastic Agents, Cardiac Glycosides, Clinical Trials as Topic, Heart Diseases, Humans, Neoplasms, Tumor Cells, Cultured, Molecular Structure, Apoptosis, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.